| NCT Number | NCT07340814 |
| Lead Sponsor | March Biosciences Inc |
| Conditions | Any Patient Treated With MB-105 |
| Enrollment | 40 participants |
| Start Date | 2026-02-27 |
| Primary Completion | 2040-10-15 (estimated) |
| Study Completion | 2040-10-15 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-14 |